Profile data is unavailable for this security.
About the company
Patterson Companies, Inc. is a specialty distributor serving the United States and Canadian dental supply markets and the United States, Canadian and the United Kingdom animal health supply markets. The Company's segments include Dental, Animal Health and Corporate. The Dental segment provides a range of consumable dental products, equipment and software, turnkey digital solutions and services to dentists, dental laboratories, institutions, and other healthcare professionals throughout North America. This segment offers consumable products including infection control, restorative materials, and instruments. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets in North America and the United Kingdom. Products it distributes include pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software.
- Revenue in USD (TTM)6.41bn
- Net income in USD193.80m
- Incorporated1992
- Employees7.70k
- LocationPatterson Companies Inc1031 Mendota Heights RdSAINT PAUL 55120-1401United StatesUSA
- Phone+1 (651) 686-1600
- Websitehttps://www.pattersoncompanies.com/
More ▼
Mergers & acquisitions
| Acquired company | PDCO:NSQ since announced | Transaction value |
|---|---|---|
| Dairy Tech Inc | 0.65% | -- |
| Relief Services For Veterinary Practitioners | 7.88% | -- |
Data delayed at least 15 minutes, as of Nov 25 2022 18:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NuVasive, Inc. | 1.20bn | -20.41m | 1.99bn | 2.90k | -- | 2.38 | 15.57 | 1.66 | -0.4583 | -0.4583 | 21.95 | 15.98 | 0.5563 | 1.01 | 5.51 | 413,299.30 | -0.9471 | 0.3758 | -1.19 | 0.4499 | 72.53 | 72.00 | -1.70 | 0.6706 | 0.7202 | 1.64 | 0.5172 | 0.00 | 8.41 | 3.43 | -72.49 | -- | 3.59 | -- |
| Silk Road Medical Inc | 126.83m | -57.09m | 1.99bn | 352.00 | -- | 32.26 | -- | 15.68 | -1.63 | -1.63 | 3.61 | 1.62 | 0.7732 | 1.88 | 9.06 | 360,321.00 | -34.80 | -- | -40.31 | -- | 73.09 | -- | -45.01 | -- | 5.29 | -16.52 | 0.5652 | -- | 34.89 | -- | -5.16 | -- | -- | -- |
| Procept Biorobotics Corp | 49.69m | -68.82m | 2.03bn | 234.00 | -- | 8.47 | -- | 40.95 | -1.56 | -1.56 | 1.13 | 5.37 | 0.1982 | 2.02 | 6.20 | 212,367.50 | -27.45 | -- | -29.34 | -- | 50.18 | -- | -138.49 | -- | 15.27 | -11.26 | 0.1744 | -- | 346.72 | -- | -12.89 | -- | -- | -- |
| AtriCure Inc. | 315.57m | -56.04m | 2.13bn | 875.00 | -- | 4.73 | -- | 6.75 | -1.23 | -1.23 | 6.92 | 9.70 | 0.5282 | 1.93 | 8.42 | 360,650.30 | -9.38 | -3.47 | -10.35 | -3.81 | 74.74 | 73.42 | -17.76 | -7.46 | 2.92 | -13.31 | 0.1353 | -- | 32.83 | 12.08 | 204.24 | -- | 4.86 | -- |
| Glaukos Corp | 284.88m | -89.61m | 2.25bn | 727.00 | -- | 4.10 | -- | 7.89 | -1.90 | -1.90 | 5.95 | 11.51 | 0.2749 | 2.55 | 8.14 | 391,850.10 | -8.65 | -6.01 | -9.20 | -6.48 | 75.91 | 77.83 | -31.45 | -15.28 | 6.84 | -8.01 | 0.3918 | -- | 30.70 | 20.78 | 58.79 | -- | 50.07 | -- |
| Helen of Troy Limited | 2.24bn | 170.74m | 2.25bn | 2.15k | 13.33 | 1.61 | 10.68 | 1.01 | 7.04 | 7.04 | 92.38 | 58.34 | 0.7951 | 2.02 | 4.78 | 1,042,117.00 | 6.07 | 9.67 | 7.69 | 12.18 | 43.42 | 42.63 | 7.63 | 10.40 | 1.02 | 13.14 | 0.4555 | -- | 5.93 | 9.73 | -8.51 | 9.17 | 38.15 | -- |
| Pacific Biosciences of California Inc | 136.97m | -299.19m | 2.29bn | 728.00 | -- | 3.65 | -- | 16.69 | -1.34 | -1.34 | 0.6137 | 2.77 | 0.0711 | 2.47 | 5.87 | 188,145.60 | -15.53 | -22.10 | -16.10 | -24.57 | 44.29 | 39.32 | -218.44 | -91.18 | 10.66 | -19.58 | 0.5886 | -- | 65.43 | 7.55 | -716.34 | -- | -6.29 | -- |
| Integer Holdings Corp | 1.32bn | 68.26m | 2.39bn | 9.00k | 35.15 | 1.76 | 15.12 | 1.81 | 2.05 | 2.16 | 39.52 | 40.90 | 0.5177 | 5.41 | 5.02 | 146,298.70 | 2.68 | 2.91 | 2.89 | 3.13 | 26.11 | 28.70 | 5.18 | 6.22 | 1.74 | 2.83 | 0.4092 | 0.00 | 13.75 | 2.57 | 20.40 | 30.18 | -1.83 | -- |
| Conmed Corp | 1.07bn | -82.72m | 2.53bn | 3.80k | -- | -- | -- | 2.37 | -2.91 | -2.91 | 34.72 | -- | -- | -- | -- | 281,203.90 | -- | 2.11 | -- | 2.36 | 55.93 | 55.04 | -7.74 | 3.66 | -- | 3.63 | -- | 69.26 | 17.18 | 5.77 | 557.16 | 33.65 | 0.1527 | 0.00 |
| Tandem Diabetes Care Inc | 790.71m | -67.93m | 2.54bn | 2.00k | -- | 6.02 | -- | 3.22 | -1.06 | -1.06 | 12.31 | 6.56 | 0.8333 | 4.45 | 7.90 | 395,356.00 | -7.16 | -15.69 | -8.47 | -19.84 | 52.00 | 52.00 | -8.59 | -15.67 | 4.20 | -19.11 | 0.4013 | -- | 40.89 | 52.85 | 145.27 | -- | 21.36 | -- |
| Patterson Companies, Inc. | 6.41bn | 193.80m | 2.85bn | 7.70k | 14.88 | 2.77 | 10.41 | 0.4449 | 1.97 | 1.97 | 65.15 | 10.59 | 2.33 | 6.18 | 17.23 | 832,181.10 | 6.98 | -0.1828 | 11.32 | -0.2691 | 20.65 | 21.18 | 3.00 | -0.0968 | 0.7965 | -- | 0.3816 | -- | 9.93 | 3.05 | 30.28 | 3.18 | -4.02 | 1.20 |
| LivaNova PLC | 1.02bn | -96.47m | 2.87bn | 3.00k | -- | 2.50 | -- | 2.82 | -1.81 | -1.81 | 18.91 | 21.43 | 0.4606 | 2.41 | 5.74 | 338,998.30 | -4.37 | -5.98 | -5.56 | -7.34 | 70.92 | 65.94 | -9.48 | -14.04 | 2.53 | 0.8195 | 0.3201 | -- | 10.82 | 1.42 | 60.90 | -- | -7.86 | -- |
| STAAR Surgical Company | 279.35m | 37.82m | 2.89bn | 692.00 | 78.12 | 9.01 | 68.88 | 10.33 | 0.7663 | 0.7663 | 5.66 | 6.64 | 0.7767 | 3.33 | 5.74 | 403,682.10 | 10.52 | 5.83 | 12.06 | 7.08 | 78.25 | 74.44 | 13.54 | 6.98 | 6.11 | 10.26 | 0.0013 | 0.00 | 41.00 | 22.83 | 314.36 | -- | 33.61 | -- |
| Adapthealth Corp | 2.89bn | 86.96m | 2.93bn | 10.70k | 34.14 | 1.35 | 6.90 | 1.01 | 0.6365 | 0.6365 | 15.52 | 16.08 | 0.5547 | 21.18 | 8.20 | 270,319.40 | 1.88 | -- | 2.08 | -- | 17.53 | -- | 3.39 | -- | 1.08 | 2.75 | 0.504 | -- | 132.35 | -- | 187.73 | -- | -- | -- |
| Inmode Ltd | 431.24m | 176.50m | 3.00bn | 362.00 | 17.47 | 5.90 | 16.93 | 6.95 | 2.06 | 2.06 | 5.05 | 6.12 | 0.8401 | 2.52 | 17.02 | 1,191,271.00 | 34.38 | 37.64 | 38.59 | 45.48 | 83.92 | 85.26 | 40.93 | 38.01 | 9.12 | 828.05 | 0.00 | 0.00 | 73.49 | 72.99 | 119.87 | 245.31 | 37.94 | -- |
| Axonics Inc | 240.92m | -75.53m | 3.25bn | 517.00 | -- | 5.92 | -- | 13.51 | -1.66 | -1.66 | 5.28 | 11.11 | 0.4037 | 1.11 | 7.58 | 465,994.20 | -12.66 | -25.46 | -13.67 | -28.70 | 70.60 | 62.16 | -31.35 | -86.62 | 6.44 | -52.96 | 0.00 | -- | 61.64 | -- | -45.80 | -- | 50.57 | -- |
Data as of Nov 25 2022. Currency figures normalised to Patterson Companies Inc's reporting currency: US Dollar USD
43.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2022 | 8.89m | 9.17% |
| BlackRock Fund Advisorsas of 30 Sep 2022 | 8.80m | 9.08% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2022 | 6.54m | 6.75% |
| Dimensional Fund Advisors LPas of 30 Sep 2022 | 4.02m | 4.15% |
| American Century Investment Management, Inc.as of 30 Sep 2022 | 2.94m | 3.03% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 2.88m | 2.97% |
| River Road Asset Management LLCas of 30 Sep 2022 | 2.78m | 2.87% |
| Westwood Management Corp. (Texas)as of 30 Sep 2022 | 2.10m | 2.17% |
| Nordea Investment Management AB (Denmark)as of 30 Sep 2022 | 1.85m | 1.91% |
| Victory Capital Management, Inc. (Investment Management)as of 30 Sep 2022 | 1.59m | 1.65% |
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
